VBI Vaccines Inc (37)

Browse by Contract Category

Contracts

Open Market Sale Agreement, dated September 3, 2021, by and between VBI Vaccines Inc. and Jefferies LLC (Filed With SEC on September 3, 2021)
Sublease signed by EMI Car Wash Systems Ltd. And SciVac Ltd effective July 11, 2021 (Filed With SEC on August 2, 2021)
Form of Amended and Restated Warrant (Filed With SEC on May 21, 2021)
Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective July 1, 2020 (Filed With SEC on May 10, 2021)
Amendment to the Collaboration and License Agreement with Brii Bioscience, effective April 8, 2021 (Filed With SEC on May 10, 2021)
Addendum #3 to sublease agreement signed by Ayalot Investment (Ramat Vered) 1994 Ltd; EMI Car Wash Systems Ltd and SciVac Ltd effective July 11, 2021 (Filed With SEC on August 2, 2021)
Amendment to the Agreement signed by NRC on March 30, 2020 and Amendment One signed by NRC on December 21, 2020 effective July 8, 2021 (Filed With SEC on August 2, 2021)
First Amendment to Loan and Guaranty Agreement, dated as of May 17, 2021, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower representative,... (Filed With SEC on May 21, 2021)
Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition for Epidemic... (Filed With SEC on May 10, 2021)
Master Commercial Services Agreement between InVentiv Commercial Services, LLC and VBI Vaccines Inc (Filed With SEC on March 2, 2021)
Amendment to the Assignment Agreement, dated February 14, 2013, by and among SciGen Ltd., SciGen (I.L.) Ltd (Filed With SEC on March 2, 2021)
Assignment Agreement, dated October 16, 2012, by and among FDS Pharma LLP, SciGen Ltd., and SciGen (I.L.) Ltd (Filed With SEC on March 2, 2021)
Assignment Agreement, dated February 14, 2012, between FDS Pharma LLP and SciGen Ltd (Filed With SEC on March 2, 2021)
Amendment One to Collaborative Research Agreement between National Research Council of Canada and Variation Biotechnologies Inc. effective December 21, 2020 (Filed With SEC on March 2, 2021)
Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective January 1, 2021 (Filed With SEC on March 2, 2021)
Description of Securities (Filed With SEC on March 2, 2021)
Lease agreement dated September 4, 2020, between 310 Hunt Club Limited and Variation Biotechnologies Inc (Filed With SEC on November 2, 2020)
Contribution Agreement, dated September 16, 2020, by and among VBI Vaccines, Inc., Variation Biotechnologies, Inc. and Her Majesty The Queen in Right of Canada as Represented by... (Filed With SEC on November 2, 2020)
Form of Warrant (Filed With SEC on May 27, 2020)
Loan and Guaranty Agreement, dated as of May 22, 2020, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower representative, each of the... (Filed With SEC on May 27, 2020)
Fifth Amendment to lease agreement among American Twine Limited Partnership and Variation Biotechnologies (US) Inc (Filed With SEC on May 6, 2020)
Sixth Amendment to lease agreement among American Twine Limited Partnership and Variation Biotechnologies (US) Inc (Filed With SEC on May 6, 2020)
Seventh Amendment to lease agreement among American Twine Owner LLC and Variation Biotechnologies (US), Inc (Filed With SEC on May 6, 2020)
Collaborative Research Agreement between National Research Council of Canada and Variation Biotechnologies Inc effective March 30, 2020 (Filed With SEC on May 6, 2020)
Form of Warrant Agreement (Filed With SEC on April 27, 2020)
Underwriting Agreement, dated April 22, 2020, by and among the Company and Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the several... (Filed With SEC on April 24, 2020)
Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective January 1, 2020 (Filed With SEC on March 5, 2020)
Waiver Agreement, dated February 25, 2020, by and among Variation Biotechnologies (US), Inc., the Guarantors party thereto, and Perceptive Credit Holdings, LP (Filed With SEC on March 5, 2020)
Description of Securities (Filed With SEC on March 5, 2020)
Lease extension and amending agreement, dated September 5, 2019, pursuant to the Sub-Sublease, dated September 1, 2014, between Iogen Corporate and the Variation Biotechnologies... (Filed With SEC on November 6, 2019)
Underwriting Agreement, dated September 19, 2019, by and among the Company and Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the several... (Filed With SEC on September 20, 2019)
Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective January 1, 2019 (Filed With SEC on February 25, 2019)
Amendment to Sublease Lease, dated January 15, 2019, by and between Green Power YE and SciVac Ltd (Filed With SEC on February 25, 2019)
Stock Purchase Agreement, dated December 4, 2018, between VBI Vaccines, Inc. and Brii Biosciences Limited (Filed With SEC on February 25, 2019)
Waiver Agreement, dated February 14, 2019, by and among Variation Biotechnologies (US), Inc., the Guarantors party thereto, and Perceptive Credit Holdings, LP (Filed With SEC on February 25, 2019)
Collaboration and License Agreement, dated December 4, 2018, between VBI Vaccines, Inc. and Brii Biosciences Limited (Filed With SEC on February 25, 2019)
Amendment No. 3 to Amended and Restated Credit Agreement and Guaranty and Amendment to Warrant, dated January 31, 2019, by and among Variation Biotechnologies (US), Inc., the... (Filed With SEC on February 5, 2019)